Discover 2,122 paid clinical trials in Allentown, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,122
Neurocognitive Functioning Following The PROMETA® Treatment Protocol In Subjects With Alcohol Dependence
for
Alcohol Dependence
Location: Philadelphia PA
Sponsor: Institute of Addiction Medicine
Sex: All
Age: 18 - 70+
Code: NCT00570388
Recruiting
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
for
Osteoarthritis, Overweight or Obesity
Location: Plymouth Meeting PA, Brooklyn NY, Long Island City NY,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07353931
Phase 3, Recruiting
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
for
Alzheimer's Disease
Location: Plymouth Meeting PA, Springfield NJ,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 60 - 70+
Code: NCT06976203
Phase 3, Recruiting
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
for
Cardiovascular Disease
Location: Horsham PA, Yardley PA, Philadelphia PA, Bridgewater NJ,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07000357
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
for
Heart Failure
Location: Horsham PA, Pennington NJ, Philadelphia PA, Somerset NJ,
Sponsor: AstraZeneca
Sex: All
Age: 40+
Code: NCT06677060
Phase 3, Recruiting
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
for
Hormone Receptor Positive HER-2 Negative Breast Cancer,
Location: Horsham PA, Philadelphia PA, Rochester NY, Richmond VA,
Sponsor: Puma Biotechnology, Inc.
Sex: All
Age: 18+
Code: NCT06369285
Phase 2, Recruiting
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
for
DLBCL, Diffuse Large B-Cell Lymphoma
Location: Horsham PA, Edgewood KY, Grand Rapids MI, Knoxville TN,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT05139017
Phase 2, Phase 3, Recruiting
Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Location: Horsham PA, Philadelphia PA, Brooklyn NY, Paramus NJ,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06119581
Phase 3, Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
for
Breast Cancer, Locally Advanced Breast Cancer,
Location: Horsham PA, New York NY, Baltimore MD, Sayre PA,
Sponsor: Olema Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT07085767
Phase 3, Recruiting
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
for
High Risk Cardiovascular Disease, Hypertension,
Location: Horsham PA, Philadelphia PA, Brick NJ, Flemington NJ,
Sponsor: Alnylam Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07181109
Phase 3, Recruiting
A Prospective, Randomized, Subject and Vision-assessor Masked, Multicenter Study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, and Mixed Clareon PanOptix Pro/Vivity Intraocular Lens Implantation in Cataract Subjects
for
Cataract
Location: Plymouth Meeting PA, Houston TX
Sponsor: Berkeley Eye Center
Sex: All
Age: 40+
Code: NCT06922084
Recruiting
A Prospective Study on the Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) in Achieving >20% Intraocular Pressure (IOP) Reduction Without Medications at 6 Months in Naive, Untreated Glaucoma Patients
for
Primary Open Angle Glaucoma, Glaucoma,
Location: Plymouth Meeting PA
Sponsor: Brian Shafer
Sex: All
Age: 18+
Code: NCT07076303
Recruiting
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities
A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
for
Alopecia Areata
Location: Plymouth Meeting PA, Boston MA, Toronto, Oakville,
Sponsor: Pfizer
Sex: All
Age: 12+
Code: NCT07733765
Phase 3, Recruiting
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
ReneuRx™ (Nerve Selective Therapy) Utilized in Lateral Hip Pain
for
Greater Trochanteric Pain Syndrome,
Location: King of Prussia PA, Sewickley PA, Chestnut Hill MA,
Sponsor: Brixton Biosciences, Inc.
Sex: All
Age: 22 - 70+
Code: NCT07568015
Recruiting
A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder
for
Social Anxiety Disorder
Location: Plymouth Meeting PA, Toms River NJ, Saint Charles MO,
Sponsor: VistaGen Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT06809179
Phase 2, Recruiting
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
for
Hidradenitis Suppurativa (HS)
Location: Plymouth Meeting PA, Philadelphia PA, New York NY,